Infliximab Biosimilar, TNF alpha Monoclonal Antibody. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research use only (RUO). Recombinant...
Alemtuzumab Biosimilar, Human CD52 Monoclonal Antibody. The research grade Alemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Abciximab Biosimilar, Glycoprotein IIb/IIIa Receptor Monoclonal Antibody. The research grade abciximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Ramucirumab Biosimilar, Human VEGFR2 Monoclonal Antibody. The research grade ramucirumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Secukinumab Biosimilar, Human IL17A Monoclonal Antibody. The research grade Secukinumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Dupilumab Biosimilar, Human IL4R alpha Monoclonal Antibody. The research grade dupilumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Evolocumab Biosimilar, Human PCSK9 Monoclonal Antibody. The research grade evolocumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype controls are available.
Eculizumab Biosimilar, Human C5 Monoclonal Antibody. Eculizumab biosimilar CHO stable cell line is available for licensing to manufacture the eculizumab biosimilar protein. The research grade eculizumab biosimilar protein is for research use only (RUO). Recombinant...
Omalizumab Biosimilar, Human IgE Monoclonal Antibody. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only (RUO). Recombinant human...
Palivizumab Biosimilar, RSV Monoclonal Antibody. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human...
